An act to add Section 11056.5 to the Health and Safety Code, relating to controlled substances.
Summary
AB 1778 would add Section 11056.5 to the Health and Safety Code to tie California’s scheduling of testosterone and dihydrotestosterone to federal controlled-substance law, but only if the federal classification becomes less restrictive. Under the bill, if either substance is removed from Schedule III under the federal Controlled Substances Act and placed in a lower schedule or exempted entirely, California would automatically treat it the same way under state law.
The measure does not change the current state classification on its own. Instead, it creates a conformity mechanism so California law would track future federal rescheduling or exemption decisions for these hormones. The bill is framed as a controlled-substances measure and would affect the state’s Health and Safety Code provisions governing drug scheduling and enforcement.
Impact
If enacted, AB 1778 would amend the California Uniform Controlled Substances Act by adding a new conformity rule for testosterone and dihydrotestosterone. The practical effect would be to reduce the need for separate state legislation if the federal government later loosens restrictions on those substances. It would primarily affect state drug scheduling, law enforcement, regulators, prescribers, pharmacies, and patients who use testosterone-based therapies, while leaving current law unchanged unless federal law changes first.
Sentiment
The available voting history suggests broad support and little opposition. The bill advanced unanimously in committee votes, including a 19-0 vote and a 9-0 vote, and was recommended to the consent calendar. No committee transcript or recorded debate is provided, so there is no evidence of significant controversy in the materials supplied. Overall, the bill appears to have been treated as a technical conformity measure rather than a contentious policy change.
Contention
The main policy issue is whether California should automatically follow federal changes for testosterone and dihydrotestosterone instead of maintaining independent state scheduling. Supporters would likely favor consistency and administrative simplicity, especially if federal law becomes less restrictive. Any potential concern would center on whether automatic conformity limits state discretion over controlled-substance policy, but the provided record does not show organized opposition or specific objections.
Adds certain psychoactive substances to the list of Schedule I controlled substances and modifies the offenses of possession of a controlled substance and delivery of a controlled substance